What Researchers Did
Researchers conducted a preliminary case series examining the short-term outcomes and MRI changes in three adult patients with sickle cell disease and aseptic osteonecrosis after treatment with hyperbaric oxygen therapy.
What They Found
Three patients with sickle cell disease and avascular necrosis received 15-40 sessions of hyperbaric oxygen therapy and were assessed 6-12 months later by MRI. They showed varying clinical outcomes and MRI changes, with subjective improvement noted, particularly in early stages.
What This Means for Canadian Patients
Canadian patients with sickle cell disease experiencing avascular necrosis might consider hyperbaric oxygen therapy as a potential treatment option, especially in early stages. However, given this is a preliminary report, they should discuss its suitability and limited evidence with their healthcare provider.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or patients.
Study Limitations
This preliminary report is limited by its small sample size of three patients, making it difficult to generalize findings.